Texas Prior Authorization Program Clinical Edit Criteria
|
|
- Bryce Kelley
- 5 years ago
- Views:
Transcription
1 Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical edit Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical edit criteria rules Logic diagram: a visual depiction of the clinical edit criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable Note: Click the hyperlink to navigate directly to that section. Revision Notes Added a new section to specify the drugs requiring prior authorization Modified criteria logic and logic diagram to identify the steps that are executed manually In the Clinical Edit Criteria Supporting Tables section, revised tables to specify the drug names and s pertinent to steps 3 and 5 of the logic diagram In the Clinical Edit Criteria Supporting Tables section, revised tables to specify the diagnosis codes pertinent to steps 4 and 7 of the logic diagram October 26, 2011 Copyright 2011 Health Information Designs, LLC 1
2 Drugs Requiring Prior Authorization Drugs Requiring Prior Authorization XYREM 500 MG/ML ORAL SOLUTION October 26, 2011 Copyright 2011 Health Information Designs, LLC 2
3 Clinical Edit Criteria Logic 1. Is the request a phone call? [ ] Yes (Go to #2) [ ] No (Deny) 2. Is the client less than (<) 16 years of age? [ ] Yes (Deny) [ ] No (Go to #3) 3. Does the client have an active claim for? [ ] Yes (Deny) [ ] No (Go to #4) 4. Does the client have a diagnosis of alcohol or substance abuse in the last 730 days? [ ] Yes (Deny) [ ] No (Go to #5) 5. Does the client have an active claim for a CNS depressant agent? [ ] Yes (Deny) [ ] No (Go to #6) 6. Is the requested dose per day less than or equal to ( ) 9 grams? [ ] Yes (Go to #7) [ ] No (Deny) 7. Does the client have a diagnosis of narcolepsy or cataplexy in the last 730 days? [ ] Yes (Approve 365 days) [ ] No (Go to #8) 8. Manual step Does the client have excessive daytime sleepiness, narcolepsy, or cataplexy? [ ] Yes (Approve 365 days) [ ] No (Deny) October 26, 2011 Copyright 2011 Health Information Designs, LLC 3
4 Clinical Edit Criteria Logic Diagram Step 1 Step 2 Step 3 Is the request a phone call? Yes Is the client < 16 years of age? No Does the client have an active claim for? Yes Deny Request No Yes No Step 4 Deny Request Deny Request Does the client have a diagnosis of alcohol or substance abuse in the last 730 days? Yes Deny Request No Step 6 Step 5 Deny Request No Is the requested dose per day 9 grams for the client? No Does the client have an active claim for a CNS depressant agent? Yes Deny Request Yes Step 7 Step 8 (Manual) Approve Request (365 days) Yes Does the client have a diagnosis of narcolepsy or cataplexy in the last 730 days? No Does the client have excessive daytime sleepiness, narcolepsy, or cataplexy? No Deny Request Yes Approve Request (365 days) October 26, 2011 Copyright 2011 Health Information Designs, LLC 4
5 Clinical Edit Criteria Supporting Tables Step 3 (active claim for ) XYREM 500 MG/ML ORAL SOLUTION Step 4 (diagnosis of alcohol or substance abuse) Required diagnosis: 1 Look back timeframe: 730 days ICD-9 Code Description 303 ALCOHOL DEPENDENCE SYNDROME 3030 ACUTE ALCOHOLIC INTOXICATION AC ALCOHOL INTOX-UNSPEC AC ALCOHOL INTOX-CONTIN AC ALCOHOL INTOX-EPISOD AC ALCOHOL INTOX-REMISS 3039 OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE ALCOH DEP NEC/NOS-UNSPEC ALCOH DEP NEC/NOS-CONTIN ALCOH DEP NEC/NOS-EPISOD ALCOH DEP NEC/NOS-REMISS 304 DRUG DEPENDENCE 3040 OPIOID TYPE DEPENDENCE OPIOID DEPENDENCE-UNSPEC OPIOID DEPENDENCE-CONTIN OPIOID DEPENDENCE-EPISOD OPIOID DEPENDENCE-REMISS 3041 SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE SEDATIVE,HYPNOTIC OR ANXIOLYTIC DEPENDENCE UNSPECIFIED SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE, CONTINUOUS SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE, EPISODIC SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE, IN REMISSION 3042 COCAINE DEPENDENCE October 26, 2011 Copyright 2011 Health Information Designs, LLC 5
6 ICD-9 Code Step 4 (diagnosis of alcohol or substance abuse) Description COCAINE DEPEND-UNSPEC COCAINE DEPEND-CONTIN COCAINE DEPEND-EPISODIC COCAINE DEPEND-REMISS 3043 CANNABIS DEPENDENCE CANNABIS DEPEND-UNSPEC CANNABIS DEPEND-CONTIN Required diagnosis: 1 Look back timeframe: 730 days CANNABIS DEPEND-EPISODIC CANNABIS DEPEND-REMISS 3044 AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE AMPHETAMIN DEPEND-UNSPEC AMPHETAMIN DEPEND-CONTIN AMPHETAMIN DEPEND-EPISOD AMPHETAMIN DEPEND-REMISS 3045 HALLUCINOGEN DEPENDENCE HALLUCINOGEN DEP-UNSPEC HALLUCINOGEN DEP-CONTIN HALLUCINOGEN DEP-EPISOD HALLUCINOGEN DEP-REMISS 3046 OTHER SPECIFIED DRUG DEPENDENCE DRUG DEPEND NEC-UNSPEC DRUG DEPEND NEC-CONTIN DRUG DEPEND NEC-EPISODIC DRUG DEPEND NEC-IN REM 3047 COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE OPIOID/OTHER DEP-UNSPEC OPIOID/OTHER DEP-CONTIN OPIOID/OTHER DEP-EPISOD OPIOID/OTHER DEP-REMISS 3048 COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG COMB DRUG DEP NEC-UNSPEC COMB DRUG DEP NEC-CONTIN COMB DRUG DEP NEC-EPISOD COMB DRUG DEP NEC-REMISS 3049 UNSPECIFIED DRUG DEPENDENCE October 26, 2011 Copyright 2011 Health Information Designs, LLC 6
7 Step 4 (diagnosis of alcohol or substance abuse) Required diagnosis: 1 Look back timeframe: 730 days ICD-9 Code Description DRUG DEPEND NOS-UNSPEC DRUG DEPEND NOS-CONTIN DRUG DEPEND NOS-EPISODIC DRUG DEPEND NOS-REMISS 305 NONDEPENDENT ABUSE OF DRUGS 3050 NONDEPENDENT ALCOHOL ABUSE ALCOHOL ABUSE-UNSPEC ALCOHOL ABUSE-CONTINUOUS ALCOHOL ABUSE-EPISODIC ALCOHOL ABUSE-IN REMISS 3052 NONDEPENDENT CANNABIS ABUSE CANNABIS ABUSE-UNSPEC CANNABIS ABUSE-CONTIN CANNABIS ABUSE-EPISODIC CANNABIS ABUSE-IN REMISS 3053 NONDEPENDENT HALLUCINOGEN ABUSE HALLUCINOG ABUSE-UNSPEC HALLUCINOG ABUSE-CONTIN HALLUCINOG ABUSE-EPISOD HALLUCINOG ABUSE-REMISS 3054 NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE, UNSPECIFIED SEDATIVE, HYPNOTIC OR ANXIOLYTIC, ABUSE, CONTINUOUS SEDATIVE, HYPNOTIC, OR ANXIOLYTIC ABUSE, EPISODIC SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE, IN REMISSION 3055 NONDEPENDENT OPIOID ABUSE OPIOID ABUSE-UNSPEC OPIOID ABUSE-CONTINUOUS OPIOID ABUSE-EPISODIC OPIOID ABUSE-IN REMISS 3056 NONDEPENDENT COCAINE ABUSE COCAINE ABUSE-UNSPEC COCAINE ABUSE-CONTINUOUS COCAINE ABUSE-EPISODIC COCAINE ABUSE-IN REMISS October 26, 2011 Copyright 2011 Health Information Designs, LLC 7
8 ICD-9 Code 3057 Step 4 (diagnosis of alcohol or substance abuse) Description Required diagnosis: 1 Look back timeframe: 730 days NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE AMPHETAMINE ABUSE-UNSPEC AMPHETAMINE ABUSE-CONTIN AMPHETAMINE ABUSE-EPISOD AMPHETAMINE ABUSE-REMISS 3059 NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE DRUG ABUSE NEC-UNSPEC DRUG ABUSE NEC-CONTIN DRUG ABUSE NEC-EPISODIC DRUG ABUSE NEC-IN REMISS ACETAMINOPHN-BUTALBITAL ACETAMINOPH-CAFF-DIHYDROCODEIN ACETAMINOPHEN-COD #2 TABLET ACETAMINOPHEN-COD #3 TABLET ACETAMINOPHEN-COD #4 TABLET ACETAMINOPHEN-CODEINE ELIXIR ACETAMINOPHN-TRAMADOL ACTIQ 200 MCG LOZENGE ACTIQ 400 MCG LOZENGE ACTIQ 600 MCG LOZENGE ACTIQ 800 MCG LOZENGE ACTIQ 1,200 MCG LOZENGE ACTIQ 1,600 MCG LOZENGE ALAGESIC CAPSULES ALAGESIC LQ ORAL SOLUTION AMBIEN 5 MG TABLET AMBIEN 10 MG TABLET AMBIEN CR 6.25 MG TABLET AMBIEN CR 12.5 MG TABLET ATIVAN 0.5 MG TABLET October 26, 2011 Copyright 2011 Health Information Designs, LLC 8
9 ATIVAN 1 MG TABLET ATIVAN 2 MG TABLET ATIVAN 2 MG/ML VIAL ATIVAN 4 MG/ML VIAL AVINZA 30 MG CAPSULE AVINZA 45 MG CAPSULE AVINZA 60 MG CAPSULE AVINZA 75 MG CAPSULE AVINZA 90 MG CAPSULE AVINZA 120 MG CAPSULE BELLADONNA-OPIUM SUPP BELLADONNA-OPIUM SUPP BUPAP TABLET BUPRENEX 0.3 MG/ML AMPUL BUPRENORPHINE 2 MG TABLET SL BUPRENORPHINE 8 MG TABLET SL BUTALB-ACETAMIN-CAFF BUTALB-ACETAMIN-CAFF BUTALBIT-ACETAMINOPHEN-CAFF CP BUTALBITAL COMPOUND CAPSULE BUTALBITAL COMPOUND TABLET BUTALBITAL-ASA-CAFFEINE CAP BUTALBITAL-ASA-CAFFEINE TABLET BUTISOL SODIUM 30 MG/5 ML ELX BUTISOL SODIUM 30 MG TABLET BUTISOL SODIUM 50 MG TABLET BUTORPHANOL 1 MG/ML VIAL BUTORPHANOL 2 MG/ML VIAL BUTORPHANOL 10 MG/ML SPRAY BUTRANS 5 MCG/HR PATCH BUTRANS 10 MCG/HR PATCH BUTRANS 20 MCG/HR PATCH CAPITAL WITH CODEINE SUSP CARISOPRODOL CPD-CODEINE TAB CEPHADYN TABLET CHLORAL HYDRATE 500 MG/5 ML October 26, 2011 Copyright 2011 Health Information Designs, LLC 9
10 COCET PLUS TABLET COCET TABLET CODEINE SULFATE 30 MG TABLET CODEINE SULFATE 60 MG TABLET CO-GESIC TABLET DEMEROL 50 MG/ML AMPUL DEMEROL 50 MG/ML AMPUL DEMEROL 75 MG/1.5 ML AMPUL DEMEROL 100 MG/ML AMPUL DEMEROL 50 MG TABLET DEMEROL 100 MG TABLET DEMEROL 50 MG/ML VIAL DEMEROL 100 MG/ML VIAL DILAUDID 2 MG TABLET DILAUDID 4 MG TABLET DILAUDID 8 MG TABLET DILAUDID-5 1 MG/ML LIQUID DILAUDID-HP 10 MG/ML AMPUL DILAUDID-HP 10 MG/ML VIAL DILAUDID-HP 250 MG VIAL DOLGIC PLUS TABLET DOLOPHINE HCL 10 MG TABLET DORAL 15 MG TABLET DURAGESIC 12 MCG/HR PATCH DURAGESIC 25 MCG/HR PATCH DURAGESIC 50 MCG/HR PATCH DURAGESIC 75 MCG/HR PATCH DURAGESIC 100 MCG/HR PATCH EDLUAR 5 MG SL TABLET EDLUAR 10 MG SL TABLET EMBEDA MG CAPSULE EMBEDA MG CAPSULE EMBEDA 50-2 MG CAPSULE EMBEDA MG CAPSULE EMBEDA MG CAPSULE EMBEDA MG CAPSULE October 26, 2011 Copyright 2011 Health Information Designs, LLC 10
11 ENDOCET TABLET ENDOCET MG TABLET ENDOCET MG TABLET ENDOCET MG TABLET ENDOCET MG TABLET ENDODAN MG TABLET ESGIC PLUS CAPSULE ESGIC-PLUS MG TABLET ESTAZOLAM 1 MG TABLET ESTAZOLAM 2 MG TABLET ETH-OXYDOSE 20 MG/ML SOLUTION EXALGO ER 8 MG TABLET EXALGO ER 12 MG TABLET EXALGO ER 16 MG TABLET FENTANYL 12 MCG/HR PATCH FENTANYL 25 MCG/HR PATCH FENTANYL 50 MCG/HR PATCH FENTANYL 75 MCG/HR PATCH FENTANYL 100 MCG/HR PATCH FENTANYL CITRATE OTFC 200 MCG FENTANYL CITRATE OTFC 400 MCG FENTANYL CITRATE OTFC 600 MCG FENTANYL CITRATE OTFC 800 MCG FENTANYL CIT OTFC 1,200 MCG FENTANYL CIT OTFC 1,600 MCG FENTORA 100 MCG BUCCAL TABLET FENTORA 200 MCG BUCCAL TABLET FENTORA 400 MCG BUCCAL TABLET FENTORA 600 MCG BUCCAL TABLET FENTORA 800 MCG BUCCAL TABLET FIORICET MG TABLET FIORINAL MG CAPSULE FLURAZEPAM 15 MG CAPSULE FLURAZEPAM 30 MG CAPSULE HALCION 0.25 MG TABLET HYCET 7.5 MG-325 MG/15 ML SOL October 26, 2011 Copyright 2011 Health Information Designs, LLC 11
12 HYDROCODON-ACETAMINOPH HYDROCODON-ACETAMINOPH HYDROCODON-ACETAMINOPH HYDROCODON-ACETAMINOPH HYDROCODON-ACETAMINOPH HYDROCODON-ACETAMINOPHEN HYDROCODON-ACETAMINOPHEN HYDROCODON-ACETAMINOPHEN HYDROCODON-ACETAMINOPHN HYDROCODON-ACETAMINOPHN HYDROCODON-ACETAMINOPHN HYDROCODON-ACETAMINOPHN HYDROCODON-ACETAMINOPHN HYDROCODON-ACETAMINOPHN HYDROCODONE-ACETAMINOPHEN SOLN HYDROCODONE BT-IBUPROFEN TAB HYDROGESIC MG CAPSULE HYDROMORPHONE 3 MG SUPPOS HYDROMORPHONE 2 MG TABLET HYDROMORPHONE 4 MG TABLET HYDROMORPHONE 8 MG TABLET HYDROMORPHONE 10 MG/ML VIAL IBUDONE MG TABLET IBUDONE MG TABLET INFUMORPH 10 MG/ML AMPUL P-F INFUMORPH 25 MG/ML AMPUL P-F KADIAN ER 10 MG CAPSULE KADIAN ER 20 MG CAPSULE KADIAN ER 30 MG CAPSULE KADIAN ER 50 MG CAPSULE KADIAN ER 60 MG CAPSULE KADIAN ER 80 MG CAPSULE KADIAN ER 100 MG CAPSULE KADIAN ER 200 MG CAPSULE LEVORPHANOL 2 MG TABLET LORAZEPAM 2 MG/ML ORAL CONCENT October 26, 2011 Copyright 2011 Health Information Designs, LLC 12
13 LORAZEPAM 0.5 MG TABLET LORAZEPAM 1 MG TABLET LORAZEPAM 2 MG TABLET LORAZEPAM 2 MG/ML VIAL LORAZEPAM 4 MG/ML VIAL LORAZEPAM INTENSOL 2 MG/ML LORCET TABLET LORCET PLUS TABLET LORTAB TABLET LORTAB TABLET LORTAB TABLET LORTAB ELIXIR LUNESTA 1 MG TABLET LUNESTA 2 MG TABLET LUNESTA 3 MG TABLET MEPERIDINE 50 MG/5 ML SOLUTION MEPERIDINE 50 MG TABLET MEPERIDINE 100 MG TABLET MEPERIDINE 25 MG/ML VIAL MEPERIDINE 50 MG/ML VIAL MEPERIDINE 100 MG/ML VIAL MEPERITAB 50 MG TABLET MEPERITAB 100 MG TABLET METHADONE 10 MG/ML ORAL CONC METHADONE 5 MG/5 ML SOLUTION METHADONE 10 MG/5 ML SOLUTION METHADONE 40 MG TABLET DISPR METHADONE HCL 5 MG TABLET METHADONE HCL 10 MG TABLET METHADONE INTENSOL 10 MG/ML METHADOSE 10 MG/ML ORAL CONC METHADOSE 10 MG TABLET METHADOSE 40 MG TABLET DISPR MORPHINE 15 MG/ML VIAL MORPHINE SULF 10 MG/5 ML SOLN MORPHINE SULF 20 MG/5 ML SOLN October 26, 2011 Copyright 2011 Health Information Designs, LLC 13
14 MORPHINE SULF 100 MG/5 ML SOLN MORPHINE SULF CR 15 MG TABLET MORPHINE SULF CR 30 MG TABLET MORPHINE SULF CR 60 MG TABLET MORPHINE SULF CR 100 MG TABLET MORPHINE SULF CR 200 MG TABLET MORPHINE SULF ER 15 MG TABLET MORPHINE SULF ER 30 MG TABLET MORPHINE SULF ER 60 MG TABLET MORPHINE SULF ER 100 MG TABLET MORPHINE SULF ER 200 MG TABLET MORPHINE SULFATE 50 MG/ML VIAL MORPHINE SULFATE IR 15 MG TAB MORPHINE SULFATE IR 30 MG TAB MS CONTIN 15 MG TABLET MS CONTIN 60 MG TABLET MS CONTIN 100 MG TABLET MS CONTIN 200 MG TABLET MS CONTIN CR 30 MG TABLET NALBUPHINE 10 MG/ML AMPUL NALBUPHINE 200 MG/10 ML VIAL NEMBUTAL SODIUM 50 MG/ML VIA NORCO TABLET NUCYNTA 50 MG TABLET NUCYNTA 75 MG TABLET NUCYNTA 100 MG TABLET ONSOLIS 200 MCG SOLUBLE FILM ONSOLIS 400 MCG SOLUBLE FILM ONSOLIS 600 MCG SOLUBLE FILM ONSOLIS 800 MCG SOLUBLE FILM ONSOLIS 1,200 MCG SOLUBLE FILM OPANA 5 MG TABLET OPANA 10 MG TABLET OPANA ER 5 MG TABLET OPANA ER 7.5 MG TABLET OPANA ER 10 MG TABLET October 26, 2011 Copyright 2011 Health Information Designs, LLC 14
15 OPANA ER 15 MG TABLET OPANA ER 20 MG TABLET OPANA ER 30 MG TABLET OPANA ER 40 MG TABLET OPIUM TINCTURE 10 MG/ML ORAMORPH SR 15 MG TABLET ORAMORPH SR 30 MG TABLET ORAMORPH SR 60 MG TABLET ORAMORPH SR 100 MG TABLET ORBIVAN CAPSULE OXYCODON-ACETAMINOPHEN OXYCODON-ACETAMINOPHEN OXYCODON-ACETAMINOPHEN OXYCODONE CONC 20 MG/ML SOLN OXYCODONE HCL 5 MG CAPSULE OXYCODONE HCL 5 MG/5 ML SOL OXYCODONE HCL 20 MG/ML SOLN OXYCODONE HCL 5 MG TABLET OXYCODONE HCL 10 MG TABLET OXYCODONE HCL 15 MG TABLET OXYCODONE HCL 20 MG TABLET OXYCODONE HCL 30 MG TABLET OXYCODONE HCL CR 80 MG TABLET OXYCODONE HCL ER 80 MG TABLET OXYCODONE-ACETAMINOPHEN OXYCODONE-ACETAMINOPHEN OXYCODONE-ACETAMINOPHEN OXYCODONE-ACETAMINOPHEN OXYCODONE-ASA TAB OXYCODONE-IBUPROFEN TAB OXYCONTIN 10 MG TABLET OXYCONTIN 15 MG TABLET OXYCONTIN 20 MG TABLET OXYCONTIN 30 MG TABLET OXYCONTIN 40 MG TABLET OXYCONTIN 60 MG TABLET October 26, 2011 Copyright 2011 Health Information Designs, LLC 15
16 OXYCONTIN 80 MG TABLET OXYMORPHONE HCL 5 MG TABLET OXYMORPHONE HCL 10 MG TABLET PANLOR DC CAPSULE PANLOR SS TABLET PENTAZOCIN-ACETAMINOPHN PENTAZOCINE-NALOXONE TABLET PERCOCET MG TABLET PERCOCET MG TABLET PERCOCET MG TABLET PERCOCET MG TABLET PERCOCET MG TABLET PERCOCET MG TABLET PERCODAN TABLET PHENOBARBITAL 20 MG/5 ML ELIX PHENOBARBITAL 15 MG TABLET PHENOBARBITAL 16.2 MG TABLET PHENOBARBITAL 30 MG TABLET PHENOBARBITAL 32.4 MG TABLET PHENOBARBITAL 60 MG TABLET PHENOBARBITAL 64.8 MG TABLET PHENOBARBITAL 97.2 MG TABLET PHENOBARBITAL 100 MG TABLET PHENOBARBITAL 65 MG/ML VIAL PHENOBARBITAL 130 MG/ML VIAL PHRENILIN FORTE CAPSULE POLYGESIC 5/500 CAPSULE PRIMALEV MG TABLET PRIMLEV MG TABLET PRIMLEV MG TABLET PRIMLEV MG TABLET PROMACET MG TABLET PROPOXYPH-ACETAMINOPHEN REPREXAIN MG TABLET REPREXAIN MG TABLET REPREXAIN MG TABLET October 26, 2011 Copyright 2011 Health Information Designs, LLC 16
17 REPREXAIN MG TABLET RESTORIL 7.5 MG CAPSULE RESTORIL 15 MG CAPSULE RESTORIL 22.5 MG CAPSULE RESTORIL 30 MG CAPSULE ROXICET CAPLET ROXICET ORAL SOLUTION ROXICET TABLET ROXICODONE 5 MG/5 ML SOLUTION ROXICODONE 5 MG TABLET ROXICODONE 15 MG TABLET ROXICODONE 30 MG TABLET ROXICODONE INTENSOL 20 MG/ML ROZEREM 8 MG TABLET RYBIX ODT 50 MG TABLET RYZOLT ER 100 MG TABLET RYZOLT ER 200 MG TABLET RYZOLT ER 300 MG TABLET SECONAL SODIUM 100 MG CAPSULE SEDAPAP TABLET SOMNOTE 500 MG SOFTGEL SONATA 5 MG CAPSULE SONATA 10 MG CAPSULE SUBOXONE 2 MG-0.5 MG SL FILM SUBOXONE 8 MG-2 MG SL FILM SUBOXONE 2 MG-0.5 MG TABLET SL SUBOXONE 8 MG-2 MG TABLET SL SUBUTEX 2 MG TABLET SL SUBUTEX 8 MG TABLET SL TALACEN CAPLET TALWIN 30 MG/ML VIAL TALWIN NX TABLET TEMAZEPAM 7.5 MG CAPSULE TEMAZEPAM 15 MG CAPSULE TEMAZEPAM 22.5 MG CAPSULE TEMAZEPAM 30 MG CAPSULE October 26, 2011 Copyright 2011 Health Information Designs, LLC 17
18 TRAMADOL HCL 50 MG TABLET TRAMADOL HCL ER 100 MG TABLET TRAMADOL HCL ER 200 MG TABLET TRAMADOL-ACETAMINOPHN TREZIX CAPSULE TRIAZOLAM 0.25 MG TABLET TRIAZOLAM MG TABLET TYLENOL WITH CODEINE #3 TABLET TYLENOL WITH CODEINE #4 TABLET TYLOX CAPSULE ULTRACET TABLET ULTRAM 50 MG TABLET ULTRAM ER 100 MG TABLET ULTRAM ER 200 MG TABLET ULTRAM ER 300 MG TABLET VICODIN TABLET VICODIN ES MG TABLET VICODIN HP TABLET VICOPROFEN MG TAB XODOL TABLET XODOL MG TABLET XODOL TABLET XOLOX MG TABLET ZALEPLON 5 MG CAPSULE ZALEPLON 10 MG CAPSULE ZAMICET SOLUTION ZEBUTAL CAPSULE ZERLOR TABLET ZOLPIDEM TART ER 12.5 MG TAB ZOLPIDEM TARTRATE 5 MG TABLET ZOLPIDEM TARTRATE 10 MG TABLET ZOLPIMIST 5 MG ORAL SPRAY ZOLVIT 10 MG-300 MG/15 ML SOL ZYDONE MG TABLET ZYDONE MG TABLET ZYDONE MG TABLET October 26, 2011 Copyright 2011 Health Information Designs, LLC 18
19 ICD-9 Code Step 7 (diagnosis of narcolepsy or cataplexy) Description Required diagnosis: 1 Look back timeframe: 730 days 347 CATAPLEXY AND NARCOLEPSY 3470 NARCOLEPSY NARCOLEPSY, WITHOUT CATAPLEXY NARCOLEPSY,WITH CATAPLEXY 3471 NARCOLEPSY IN CONDITIONS CLASSIFIED ELSEWHERE NARCOLEPSY IN CONDITIONS CLASSIFIED ELSEWHERE, WITHOUT CATAPLEXY NARCOLEPSY IN CONDITIONS CLASSIFIED ELSEWHERE,WITH CATAPLEXY October 26, 2011 Copyright 2011 Health Information Designs, LLC 19
20 Publication History The Publication History records the publication iterations and revisions to this document. Notes for the most current revision are also provided in the Revision Notes on the first page of this document. Publication Date Notes 03/09/2011 Initial publication and posting to website 10/26/2011 Added a new section to specify the drugs requiring prior authorization Modified criteria logic and logic diagram to identify the steps that are executed manually In the Clinical Edit Criteria Supporting Tables section, revised tables to specify the drug names and s pertinent to steps 3 and 5 of the logic diagram In the Clinical Edit Criteria Supporting Tables section, revised tables to specify the diagnosis codes pertinent to steps 4 and 7 of the logic diagram October 26, 2011 Copyright 2011 Health Information Designs, LLC 20
Xyrem (Sodium Oxybate)
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationOpiate/Benzodiazepine/Muscle Relaxant Combinations
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Opiate/Benzodiazepine/Muscle Relaxant Combinations Clinical Edit Information Included in this Document Drugs requiring prior authorization:
More informationCapital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have
More informationGeneric Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE
STATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE 3 Great Circle Road NASHVILLE, TENNESSEE 37243 This notice is to advise
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Opioid Immediate Release Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Opioid Immediate Release Prime Therapeutics will review Prior Authorization
More informationNew Hampshire Healthy Families CLINICAL POLICY
New Hampshire Healthy Families CLINICAL POLICY DEPARTMENT: Pharmacy DOCUMENT NAME: Opioid Analgesics PAGE: 1 o f 6 REFERENCE NUMBER: NH.PPA.13 EFFECTIVE DATE: 6/1/2016 REPLACES DOCUMENT: N/A RETIRED: REVIEWED:
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Controlled Substance Analgesic and Narcotic Antagonist Quantity Limitations Table of Contents Coverage Policy... 1 General Background... 6 Coding/Billing
More informationOpioid Analgesic/Opioid Combination Products
Opioid Analgesic/Opioid Combination Products Override(s) Quantity Limit Approval Duration 1 year Generic Name Brand Name Quantity Limit 320.5mg/30mg/16mg 356.4mg/30mg/16mg 325mg/30mg/16mg Trezix (new formulation)
More informationBeneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical
More informationOpioid Management Program October 2018
Opioid Management Program October 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of
More informationOpioid Analgesic/Opioid Combination Products
Market DC Opioid Analgesic/Opioid Combination Products Override(s) Quantity Limit Approval Duration 1 year Generic Name Brand Name Quantity Limit APAP/Caf/Dihydrocodeine 320.5mg/30mg/16mg APAP/Caf/Dihydrocodeine
More informationOpioid Management Program May 2018
Opioid Management Program May 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of daily
More informationPrior Authorization Opioid Overutilization 2017
Drugs Requiring Prior Authorization Label Name ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE CAPSULE ACETAMINOPHEN/CODEINE SOLUTION ACETAMINOPHEN/CODEINE TABLET ASCOMP/CODEINE CAPSULE BUTALBITAL/CAFFEINE/ACETAMINOPHEN/CODEINE
More informationAPPROVED PA CRITERIA. Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION
Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION PROVIDER GROUP Pharmacy Opioid Products Indicated for Pain Management MANUAL GUIDELINES All dosage forms
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen
More informationPequot Health Care Opioid Analgesic Quantity Program*
Pequot Health Care 1 Annie George Drive Mashantucket, CT 06338 Phone: 1-888-779-6638 Fax: 1-860-396-6494 Pequot Health Care Opioid Analgesic Quantity Program* Effective January 2018 *Quantity Program limits
More informationSection 2 Class III, IV & V Pharmaceuticals Page 13
Section 2 Class III, IV & V Pharmaceuticals Page 13 ACETAMINOPHEN W/ CODEINE #3 30MG TABS (GENERIC TYLENOL) #100 41.99 ACETAMINOPHEN W/ CODEINE #3 30MG TABS #1000 298.99 ACETAMINOPHEN W/ CODEINE #4 60MG
More informationMorphine Equivalent Dosing
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by the Texas Medicaid Vendor Drug Program to ensure appropriate and safe utilization. Clinical
More informationPrescription Drug Monitoring Reference Guide: 2017
Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Test Codes Test Codes Drug/Drug Class P P,D,M P,D D,M D Alcohol Metabolites 90079 16910 92142 16217 Amphetamines 92222 70245
More informationPharmacy Medical Necessity Guidelines: Opioid Analgesics
Pharmacy Medical Necessity Guidelines: Effective: January 1, 2019 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
More informationCNS DEPRESSANT OVERDOSE
Signs and symptoms of CNS depressant overdose include: altered mental status, respiratory depression, hypotension, bradycardia, pulmonary edema, coma, and constricted pupils (opioids only). The following
More informationThe original MED criteria can be referenced at the Texas Vendor Drug Program website located at
Morphine Equivalent Dosing (MED) Clinical Edit Criteria Drug/Drug Class Morphine Equivalent Dosing (MED) Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical
More informationMEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111
POLICY: Medicare Part D Formulary-Level Cumulative Opioid and Opioid/Buprenorphine POS Edits MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111 Policy for contracts H3351, S3521 and H3335
More informationOpiate Overutilization
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)
ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect
More informationMedication Policy Manual. Topic: Immediate-release (IR) Opioid Medication Products for Pain. Date of Origin: January 1, 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Topic: Immediate-release (IR) Opioid Medication Products for Pain Policy No: dru516 Date of Origin: January
More informationCarefirst. +.V Family of health care plans
Family of health care plans Prior Authorization Form 1361M Opioids ER MME Limit and Post Limit This fax machine is located in a secure location as required by HPAA regulations. Complete/review information,
More informationBeneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical
More informationNarcotics in Workers Compensation
NCCI RESEARCH BRIEF December 2009 by Barry Lipton, Chris Laws, and Linda Li Narcotics in Workers Compensation Introduction Narcotics account for nearly one quarter of all workers compensation (WC) prescription
More information1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I
chedule II Controlled ubstances: Basics and Beyond James L. Besier, Ph.D., R.Ph., FAHP Adjunct Associate Professor College of Nursing Adjunct Assistant Professor James L. Winkle College of Pharmacy University
More informationPrescription Drug Abuse: Colorado and Nationwide
Prescription Drug Abuse: Colorado and Nationwide Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Associate Professor, University of Colorado School of Medicine 1 What s the Problem?
More information: Opioid Quantity Limits
March 7, 2017 2017-09: Opioid Quantity Limits The Louisiana Department of Health (LDH), in conjunction with the Louisiana Medicaid Drug Utilization Review (DUR) Board, has revised quantity limits for selected
More informationDisposal by Flushing of Certain Unused Medicines: What
Disposal by Flushing of Certain Unused Medicines: What You Should Know Drugs Page 1 of 5 Disposal by Flushing of Certain Unused Medicines: What You Should Know Overview Frequently Asked Questions List
More informationPrior Authorization for Opioid Products Indicated for Pain Management
Kansas Medical Assistance Program PA Phone 800-933-6593 PA Fax 800-913-2229 Amerigroup PA Pharmacy Phone 855-201-7170 PA Pharmacy Fax 800-601-4829 Sunflower PA Pharmacy Phone 877-397-9526 PA Pharmacy Fax
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Opioid Therapy Table of Contents Coverage Policy... 1 General Background... 4 Coding/Billing Information... 7 References... 7 Effective Date..1/1/2018 Next
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of drugs by drug class
More informationDrug Use Evaluation: Short Acting Opioids (SAO)
Drug Use Evaluation: Short Acting Opioids (SAO) Summary Short acting opioid analgesics are one of the most prescribed (top 10) and highest cost (top 20) medication classes for the Oregon Fee For Service
More informationCHANGES TO YOUR DRUG LIST
CHANGES TO YOUR DRUG LIST More generics and lower-cost brands to help you stay healthy and save money At Cigna, it s our goal to offer you access to coverage for safe, effective and affordable medications.
More information15 mg morphine 10 mg hydrocodone
Cari untuk: Cari Cari 15 mg morphine 10 mg hydrocodone 3-2-2013 Convert From CALCULATED MORPHINE EQUIVALENT BY RESOURCE: Average ( mg ) Range ( mg ) Standard Deviation of Sample ( mg ) Hydrocodone. I usually
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More information10 mg hydrocodone equals how much oxycodone
Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)
More informationOpioid Capture in the AHSQC Can we reduce use by measuring it? Michael Reinhorn MD, MBA, FACS Dept of Surgery, Newton Wellesley Hospital
Opioid Capture in the AHSQC Can we reduce use by measuring it? Michael Reinhorn MD, MBA, FACS Dept of Surgery, Newton Wellesley Hospital Disclosure Davol/Bard Consultant Medtronic Physician Advisory Honorarium
More informationDuragesic (Fentanyl Transdermal)
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationPrescription Drug Dispensing in Oregon
Drug Dispensing in Oregon January 1, 2012 - December 31, 2012 Schedules II-IV Medications Dispensed in Oregon Linn County PUBLIC HEALTH DIVISION Drug Monitoring Program Drug Dispensing in Oregon: January
More informationUrine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
More informationPRESCRIPTION DRUG LIST CHANGES
PRESCRIPTION DRUG LIST CHANGES Cigna Pharmacy Management The medications listed below are changing coverage (or cost levels) on Cigna s Prescription Drug List. Changes are listed by drug list and by the
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 7/1/2017, Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of
More informationDisposal of Unused Medicines: What You Should Know
1 of 8 3/12/16 11:14 PM U.S. Food and Drug Administration Protecting and Promoting Your Health Disposal of Unused Medicines: What You Should Know Topics on this page Overview List of Medicines Recommended
More informationCompensation Practice & Quality Department Replaced by PD#C10-1 January 27, 2017
Compensation Practice & Quality Department Replaced by PD#C10-1 January 27, 2017 PRACTICE DIRECTIVE #C10-1 TOPIC: Claims with Opioids, Sedative/Hypnotics or Other Prescribed Potentially Addictive Drugs
More informationBeneficiary Advisory Panel Handout Uniform Formulary Decisions 6 Jan 2011
Beneficiary Advisory Panel Handout Uniform Formulary Decisions 6 Jan 2011 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness
More informationSession II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids
Learning Objectives for Session II Session II Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between Upon completion of this module, the participants will be
More informationHarvard Pilgrim Health Care Prescription Drug List
Harvard Pilgrim Health Care Prescription Drug List PREMIUM FORMULARY THREE-TIER DRUG LIST (2016) BY CATEGORY This list is subject to change at any time. Harvard Pilgrim Health Care includes Harvard Pilgrim
More informationPARTICIPANT GENERAL INFORMATION
PARTICIPANT GENERAL INFORMATION Instructions: Please complete entire form (print) First name: Last Name: Other names used: Street address: City/State/Zip: County: Region: East TN Middle West Social Security
More informationEquianalgesic Dosing of Opioids for Pain Management
PL Detail-Document #300405 This PL Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER April 2014 Equianalgesic Dosing of Opioids for Pain Management
More informationDisposal of Unused Medicines: What You Should Know
1 of 8 04/27/2016 1:37 AM U.S. Food and Drug Administration Protecting and Promoting Your Health Disposal of Unused Medicines: What You Should Know Topics on this page (http://www.fda.gov/aboutfda/aboutthiswebsite
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More information20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days
Pre - PA Allowance Quantity Extended Release Tablets or Capsules 90 MME/day Medication Strength Avinza (morphine) 60mg, 75mg, 90mg Embeda (morphine /naltrexone) 50/2mg, 60/2.4mg, 80/3.2mg Exalgo (hydromorphone)
More informationNational 800 Phone Number. What is Misuse? Iowa s PCC. Commonly Misused Rx Drugs. Pharmageddon: The Rx Drug Abuse Crisis 04/07/14 1
Pharmageddon: The Rx Drug Abuse Crisis National 800 Phone Number Works just like 911 Program your cell phone! Linda B. Kalin, RN, BS, CSPI Director Linda.Kalin@unitypoint.org Hotline: 800-222-1222 Office:
More informationAppendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data
Data Supplement for Kennedy-Hendricks et al. (10.1176/appi.ps.201600056) Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data Un-weighted
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More informationHow To Green My Pharmacy. Prepared and presented by Luna El Bizri,Pharm-D, Community Pharmacist
How To Green My Pharmacy Prepared and presented by Luna El Bizri,Pharm-D, Community Pharmacist Learning Objectives At the end of this presentation, pharmacists will be able to : 1. Understand the negative
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationAPREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More informationused for dealing with anxiety. Both of the drugs are also given to patients for dealing with pain activated by damaged or hypersensitive nerves that i
Aspirin (also classified under NSAIDs or acetylsalicylic acid). Morphine and morphine sustained release (MS-Contin, Avinza, Kadian) Oxymorphone (Opana, Opana ER) Hydrocodone with acetaminophen (Lortab
More informationTechnician Tutorial: Scheduled Drugs
(Page 1 of 8) Technician Tutorial: Scheduled Drugs In the U.S., the federal Controlled Substances Act (CSA) regulates controlled substances. The U.S. Drug Enforcement Administration (DEA), which is a part
More informationHarvard Pilgrim Health Care Prescription Drug List
Harvard Pilgrim Health Care Prescription Drug List PREMIUM FORMULARY THREE-TIER (2017) BY CATEGORY This list is subject to change at any time. Harvard Pilgrim Health Care includes Harvard Pilgrim Health
More informationAETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization
AETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization Policy applies to all formulary and non-formulary schedules II V opioid narcotics, including tramadol and codeine, as
More informationWhat Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital
What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.
More informationA Statewide Evaluation of Opioid Prescribing Patterns with an Emphasis on Drug Diversion and Substance Abuse
A Statewide Evaluation of Opioid Prescribing Patterns with an Emphasis on Drug Diversion and Substance Abuse INVESTIGATIVE TEAM: STEERING COMMITTEE FOR THE TUFTS HEALTH CARE INSTITUTE ON OPIOID RISK MANAGEMENT
More informationCHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?
CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult
More information2014 FORMULARY LIST OF COVERED DRUGS
PLEASE READ: This formulary was updated on January 1, 2014. For more recent information or other questions, please contact Viva Medicare Member Services at 1-800-633-1542 or, for TTY users, 711, Monday
More informationObjectives. Controversy. Pain. Risk Stratification 1/7/2012
Objectives Strategies in Pain Management: Scheduled, Breakthrough, and Dose Adjustments Tamara M. Green, Pharm.D PGY-1 Resident Florida A & M University Classify and distinguish between different types
More informationPrescription Drug Guide
2019 Prescription Drug Guide Humana Medicare Employer Plan Formulary List of covered drugs PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER I N THI S PLAN. 1 This formulary was
More informationTribute 2018 Formulary 2018 Quantity Limit Criteria
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More informationResponsible Quantity Program Effective 4/1/10. Abilify oral solution
Abilify Abilify Discmelt Abilify oral solution Aciphex Actiq Page 1 of 9 750 ml 120 units Actonel 5 mg, 30 mg Actonel 35 mg 4 tabs Actonel 75 mg 2 tabs Actonel 150 mg 1 tab Actonel with Calcium Adcirca
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Oral Drugs requiring prior authorization: the list of drugs requiring prior
More informationKansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria
APREPITANT Kansas Health Advantage (HMO SNP) 2018 Formulary Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL
More informationMorphine Sulfate Hydromorphone Oxymorphone
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.33 Subject: Morphine Drug Class Page: 1 of 8 Last Review Date: June 19, 2015 Morphine Sulfate Hydromorphone
More informationProposed Changes to Existing Measure for HEDIS : Use of Opioids at High Dosage (UOD)
Proposed Changes to Existing Measure for HEDIS 1 2020: Use of Opioids at High Dosage (UOD) NCQA seeks comments on proposed revisions to the Use of Opioids at High Dosage HEDIS measure. The current measure
More informationAddressing Drug Diversion
Webinar Objectives Addressing Drug Diversion Bernice Burkarth, MD, HMDC, FAAHPM BBurkarth@treasurehealth.org October12, 2017 At the completion of this Webinar, participants will be able to: Identify tools
More informationDemystifying Opioid Conversion Calculations
Demystifying Opioid Conversion Calculations Stephanie Cheng, PharmD, MPH, BCGP Clinical Pharmacist Hospice Pharmacy Solutions November 28, 2018 Learning Objectives After this presentation, you should be
More informationThe Opioid Epidemic: What do we need to know?
The Opioid Epidemic: What do we need to know? & Regional Conference Synergy: Connect, Communicate, Collaborate May 9-12, 2018 Multicultural Development Institute, Inc. Objectives 1. Learn the history of
More information1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
More informationPain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
More informationDrug Use Evaluation: Gabapentin Use in the FFS Population
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationSTEP THERAPY WITH QUANTITY LIMIT AND POST LIMIT PRIOR AUTHORIZATION CRITERIA. AVINZA (morphine extended-release capsules)
Carelirst. +.V Family of health care plans cvs caremarktm STEP THERAPY WITH QUANTITY LIMIT AND POST LIMIT PRIOR AUTHORIZATION CRITERIA DRUG CLASS EXTENDED-RELEASE OPIOID ANALGESICS BRAND NAME* (generic)
More informationLesson 5 - Regulations and Standards Assignment Answer Key
Assignment 1 Critical Thinking Question Lesson 5 - Regulations and Standards Assignment Answer Key 1. Should a health care organization punish individuals for reporting prescription errors that they made
More informationAcetaminophen/Aspirin/Ibuprofen Containing Immediate Release Opioid Analgesics: Quantity Limit Policy
DRUG POLICY Acetaminophen/Aspirin/Ibuprofen Containing Immediate Release Opioid Analgesics: Quantity Limit Policy BENEFIT APPLICATION Benefit determinations are based on the applicable contract language
More informationIS PERCOCET GOOD TATTOO PAIN RELIEVER FOR DOGS
IS PERCOCET GOOD TATTOO PAIN RELIEVER FOR DOGS Is Percocet Good Tattoo Pain Reliever For Dogs Can u mix percocet and suboxone Take suboxone with percocet How much does percocet prescription cost Oxycodone
More informationDrug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans
FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA
More informationUrine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
More informationHarvard Pilgrim Health Care Prescription Drug List
Harvard Pilgrim Health Care Prescription Drug List VALUE FORMULARY FIVE-TIER DRUG (2017) BY CATEGORY This list is subject to change at any time. Harvard Pilgrim Health Care includes Harvard Pilgrim Health
More information